Pharmaceutical Promotion at Its Productivity Frontier
* Reuters is not responsible for the content in this press release.
Briefing Note from Blue Spoon Consulting Updated to Reflect IMS Health v. Ayotte NEW YORK--(Business Wire)-- Blue Spoon Consulting Group, LLC, today published a briefing note that looks at the interplay of market dynamics influencing the pharmaceutical, marketing services, and data vendor industries. Available for download through the Blue Spoon Consulting website (www.bluespoonconsulting.com), this is a systemic look at structural change affecting pharmaceutical marketers, and integrates the Supreme Court`s refusal to review New Hampshire`s data-mining law, IMS Health v. Ayotte. By exploring the deeper and more fundamental forces shaping the contours of the future, the briefing note provides context to craft strategy in an age of transition. Blue Spoon is a leading strategy and marketing innovation consultancy serving the global pharmaceutical industry. We are unique with an ability to create at a system level, an approach that enables an evolutionary leap in solutions for growth and competitive advantage. Visit: www.bluespoonconsulting.com. Blue Spoon Consulting John Singer, 917-538-4239 john@bluespoonconsulting.com Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters